SINT
Sintx Technologies, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Buy
+30/100
Last price
2.18
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
2.18
Day high
2.24
Day low
2.12
Volume
50.42K
Market cap
$14.53M
P/E (TTM)
—
52W range
1.40 – 4.64
Trailing performance
Returnvs SPY
1W
+7.39%
+5.4%
1M
+33.74%
+32.6%
3M
+21.79%
+17.3%
6M
-18.05%
-36.2%
YTD
-43.52%
-57.8%
1Y
-44.67%
-61.1%
3Y
-98.65%
-180.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SINT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.48M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Apr 13, 26 | ELMORE ROBERT RYAN President |
STOCK | 4.91K | $14.16K | Direct |
| Mar 2, 26 | LYONS CHRISTOPHER MICHAEL Director |
BUY | 8.29K | $24.09K | Direct |
| Feb 23, 26 | MOYES JAY M Director |
BUY | 1.00K | $2.91K | Direct |
| Feb 18, 26 | ANDERSON MARK LEWIS Director |
BUY | 3.00K | $9.06K | Direct |
| Dec 8, 25 | HONIGBLUM GREGG R. Chief Investment Officer |
BUY | 8.20K | $34.90K | Direct |
| Dec 5, 25 | HONIGBLUM GREGG R. Chief Investment Officer |
STOCK | 53.87K | $0 | Direct |
| Dec 5, 25 | HONIGBLUM GREGG R. Chief Investment Officer |
BUY | 65.00K | $255.35K | Direct |
| Nov 7, 25 | HONIGBLUM GREGG R. Chief Investment Officer |
BUY | 10.00K | $31.90K | Direct |
| Oct 20, 25 | OLSON ERIC K Chief Executive Officer |
BUY | 5.80K | $19.72K | Direct |
| Aug 26, 25 | MOYES JAY M Director |
BUY | 3.00K | $10.76K | Direct |
| Aug 26, 25 | HONIGBLUM GREGG R. Chief Investment Officer |
BUY | 50.00K | $185.00K | Direct |
| Aug 22, 25 | OLSON ERIC K Chief Executive Officer |
BUY | 10.47K | $37.47K | Direct |
| Jun 18, 25 | ANDERSON MARK LEWIS Director |
BUY | 10.00K | $33.00K | Direct |
| Apr 24, 25 | ANDERSON MARK LEWIS Director |
BUY | 5.00K | $11.80K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDERSON MARK LEWIS |
Director | 18.00K | Purchase |
ELMORE ROBERT RYAN |
President | 4.91K | Stock Award(Grant) |
HONIGBLUM GREGG R. |
Chief Investment Officer | 201.07K | Purchase |
LYONS CHRISTOPHER MICHAEL |
Director | 8.29K | Purchase |
MOYES JAY M |
Director | 4.00K | Purchase |
OLSON ERIC K |
Chief Executive Officer | 30.77K | Purchase |
Fundamentals
Market cap$14.53M
Enterprise value$14.09M
Revenue (TTM)$1.33M
Gross profit$703.00K
EBITDA$-11.34M
Net income$-18.00M
EPS (TTM)$-4.91
Free cash flow$-5.91M
Total cash$3.59M
Total debt$3.15M
Book value / share$0.73
Shares outstanding6.66M
Float5.48M
Short % of float1.55%
Dividend yield0.00%
Beta (5Y)0.59
Valuation & profitability ratios
Trailing P/E—
Forward P/E-2.02
PEG ratio—
Price / sales—
Price / book2.99
EV / revenue10.59
EV / EBITDA-1.24
Gross margin52.86%
Operating margin-638.50%
Profit margin0.00%
Return on equity-255.86%
Return on assets-74.24%
Debt / equity65.24
Current ratio2.36
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $729.00K | $1.25M | $1.23M | $601.00K | -41.5% |
| Operating revenue | $729.00K | $1.25M | $1.23M | $601.00K | -41.5% |
| Cost of revenue | $557.00K | $811.00K | $784.00K | $265.00K | -31.3% |
| Gross profit | $172.00K | $435.00K | $442.00K | $336.00K | -60.5% |
| Research & development | $4.59M | $5.20M | $8.71M | $6.45M | -11.8% |
| Selling, general & admin | $6.44M | $4.61M | $5.36M | $5.33M | +39.6% |
| Total operating expense | $10.89M | $9.47M | $13.80M | $11.67M | +15.0% |
| Operating income | -$10.72M | -$9.04M | -$13.36M | -$11.34M | -18.6% |
| Net interest income | $123.00K | $78.00K | $133.00K | $6.00K | +57.7% |
| Pre-tax income | -$10.36M | -$11.02M | -$8.26M | -$12.04M | +6.0% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$10.36M | -$11.02M | -$8.26M | -$12.04M | +6.0% |
| Net income to common | -$17.08M | -$11.02M | -$8.29M | -$16.49M | -55.0% |
| Basic EPS | -6.16 | -14.87 | -443.47 | -10,934.00 | +58.6% |
| Diluted EPS | -6.16 | -15.19 | -624.47 | -12,162.00 | +59.4% |
| EBIT | -$10.31M | -$10.99M | -$8.26M | -$12.02M | +6.2% |
| EBITDA | -$9.65M | -$9.61M | -$6.60M | -$11.06M | -0.4% |
| Basic shares | 2.77M | 741.25K | 18.68K | 1.51K | +274.2% |
| Diluted shares | 2.77M | 744.78K | 21.79K | 1.59K | +272.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.14M | $3.60M | $3.34M | $6.25M | +15.1% |
| Cash & short-term investments | $4.14M | $3.60M | $3.34M | $6.25M | +15.1% |
| Accounts receivable | $178.00K | $196.00K | $685.00K | $328.00K | -9.2% |
| Inventory | $825.00K | $502.00K | $888.00K | $284.00K | +64.3% |
| Total current assets | $5.65M | $4.52M | $5.53M | $7.21M | +25.0% |
| Property, plant & equipment | $2.93M | $4.08M | $8.92M | $8.00M | -28.1% |
| Goodwill & intangibles | $444.00K | $16.00K | $21.00K | $26.00K | +2,675.0% |
| Total assets | $9.51M | $9.41M | $15.37M | $15.77M | +1.0% |
| Total current liabilities | $3.73M | $1.98M | $2.91M | $8.08M | +88.3% |
| Current debt | $7.00K | $32.00K | $46.00K | $160.00K | -78.1% |
| Long-term debt | — | — | — | $368.00K | — |
| Total debt | $3.25M | $4.03M | $4.25M | $2.89M | -19.3% |
| Total liabilities | $6.58M | $5.52M | $6.59M | $10.07M | +19.2% |
| Retained earnings | -$292.10M | -$281.74M | -$270.71M | -$262.45M | -3.7% |
| Shareholder equity | $2.93M | $3.89M | $8.77M | $5.70M | -24.8% |
| Working capital | $1.92M | $2.54M | $2.63M | -$869.00K | -24.5% |
| Net tangible assets | $2.48M | $3.88M | $8.75M | $5.68M | -35.9% |
| Shares issued | 3.97M | 1.34M | 26.60K | 2.71K | +195.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$10.36M | -$11.02M | -$8.26M | -$12.04M | +6.0% |
| Depreciation & amortisation | $662.00K | $1.38M | $1.66M | $963.00K | -52.2% |
| Stock-based compensation | $2.00M | $82.00K | $291.00K | $369.00K | +2,334.1% |
| Change in working capital | -$356.00K | $286.00K | -$1.55M | -$55.00K | -224.5% |
| Operating cash flow | -$8.57M | -$8.64M | -$14.12M | -$10.26M | +0.8% |
| Capital expenditure | -$189.00K | -$690.00K | -$530.00K | -$1.41M | +72.6% |
| Investing cash flow | $913.00K | -$194.00K | -$501.00K | -$1.10M | +570.6% |
| Share buybacks | -$133.00K | $0 | -$2.00K | $0 | — |
| Financing cash flow | $8.20M | $9.09M | $11.71M | $3.34M | -9.8% |
| Free cash flow | -$8.76M | -$9.33M | -$14.64M | -$11.67M | +6.1% |
| End cash position | $4.14M | $3.60M | $3.34M | $6.25M | +15.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $447.00K | $300.00K | $188.00K | $150.00K | $100.00K | — | +49.0% |
| Operating revenue | $447.00K | $300.00K | $188.00K | $150.00K | $100.00K | — | +49.0% |
| Cost of revenue | $174.00K | $236.00K | $102.00K | $115.00K | $94.00K | — | -26.3% |
| Gross profit | $273.00K | $64.00K | $86.00K | $35.00K | $6.00K | — | +326.6% |
| Research & development | $573.00K | $364.00K | $969.00K | $1.26M | $1.24M | — | +57.4% |
| Selling, general & admin | $2.59M | $2.93M | $1.50M | $2.16M | $1.44M | — | -11.7% |
| Total operating expense | $3.16M | $3.27M | $2.40M | $3.39M | $2.67M | — | -3.4% |
| Operating income | -$2.89M | -$3.21M | -$2.32M | -$3.35M | -$2.67M | — | +9.9% |
| Net interest income | $10.00K | $10.00K | $33.00K | $30.00K | $32.00K | — | 0.0% |
| Pre-tax income | -$2.71M | -$2.82M | -$2.21M | -$3.54M | -$2.32M | — | +4.1% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — | — |
| Net income | -$2.71M | -$2.82M | -$2.21M | -$3.54M | -$2.32M | — | +4.1% |
| Net income to common | -$3.63M | -$2.82M | -$2.21M | -$10.26M | -$2.32M | — | -28.7% |
| Basic EPS | -0.75 | -0.70 | — | -3.46 | -0.91 | -1.29 | -7.1% |
| Diluted EPS | -0.75 | -0.70 | — | -3.46 | -0.91 | -1.29 | -7.1% |
| EBIT | -$2.70M | -$2.81M | -$2.20M | -$3.53M | -$2.30M | — | +3.7% |
| EBITDA | -$2.55M | -$2.65M | -$2.04M | -$3.37M | -$2.15M | — | +3.9% |
| Basic shares | 4.85M | 4.01M | — | 2.96M | 2.54M | 1.77M | +20.8% |
| Diluted shares | 4.85M | 4.01M | — | 2.96M | 2.54M | 1.77M | +20.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.59M | $1.89M | $4.14M | $6.25M | $4.32M | +90.0% |
| Cash & short-term investments | $3.59M | $1.89M | $4.14M | $6.25M | $4.32M | +90.0% |
| Accounts receivable | $329.00K | $364.00K | $178.00K | $120.00K | $97.00K | -9.6% |
| Inventory | $2.25M | $1.39M | $825.00K | $447.00K | $355.00K | +61.5% |
| Total current assets | $7.03M | $4.32M | $5.65M | $7.39M | $5.55M | +62.5% |
| Property, plant & equipment | $2.73M | $2.79M | $2.93M | $3.04M | $3.11M | -2.2% |
| Goodwill & intangibles | $427.00K | $435.00K | $444.00K | $452.00K | $14.00K | -1.8% |
| Total assets | $10.43M | $7.81M | $9.51M | $11.36M | $9.20M | +33.5% |
| Total current liabilities | $2.98M | $4.17M | $3.73M | $4.35M | $2.16M | -28.6% |
| Current debt | $102.00K | $106.00K | $7.00K | $59.00K | $109.00K | -3.8% |
| Total debt | $3.15M | $3.26M | $3.25M | $3.39M | $3.53M | -3.4% |
| Total liabilities | $5.60M | $6.91M | $6.58M | $7.30M | $5.21M | -18.9% |
| Retained earnings | -$297.63M | -$294.92M | -$292.10M | -$289.89M | -$286.35M | -0.9% |
| Shareholder equity | $4.83M | $904.00K | $2.93M | $4.07M | $3.99M | +434.3% |
| Working capital | $4.05M | $152.00K | $1.92M | $3.05M | $3.39M | +2,563.2% |
| Net tangible assets | $4.40M | $469.00K | $2.48M | $3.62M | $3.97M | +838.8% |
| Shares issued | 6.41M | 4.17M | 3.97M | 3.67M | 2.76M | +53.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$2.71M | -$2.82M | -$2.21M | -$3.54M | -$2.32M | — | +4.1% |
| Depreciation & amortisation | $154.00K | $156.00K | $160.00K | $159.00K | $153.00K | — | -1.3% |
| Stock-based compensation | $353.00K | $530.00K | $651.00K | $888.00K | $280.00K | — | -33.4% |
| Change in working capital | -$321.00K | $63.00K | -$804.00K | -$154.00K | -$129.00K | — | -609.5% |
| Operating cash flow | -$2.77M | -$2.49M | -$2.34M | -$2.52M | -$2.41M | — | -11.1% |
| Capital expenditure | -$84.00K | -$7.00K | -$42.00K | -$84.00K | — | -$63.00K | -1,100.0% |
| Investing cash flow | -$84.00K | -$7.00K | -$42.00K | $666.00K | $352.00K | — | -1,100.0% |
| Share buybacks | $0 | $0 | $0 | $0 | -$47.00K | — | — |
| Financing cash flow | $4.55M | $247.00K | $276.00K | $3.78M | -$123.00K | — | +1,742.9% |
| Free cash flow | -$2.85M | -$2.50M | -$2.39M | -$2.60M | -$2.41M | — | -14.1% |
| End cash position | $3.59M | $1.89M | $4.14M | $6.25M | $4.32M | — | +90.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.73 | -0.75 | -2.7% |
| Mar 2026 | -0.66 | -0.70 | -6.1% |
| Dec 2025 | -0.55 | — | — |
| Sep 2025 | -0.55 | -3.46 | -529.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.31 | 3 | $1.33M | +541.0% |
| Next quarter | -0.34 | 3 | $1.05M | +262.5% |
| Current year | -1.83 | 3 | $3.23M | +217.2% |
| Next year | -1.08 | 3 | $5.80M | +79.7% |
Analyst targets & ownership
Mean target$9.25
High target$12.50
Low target$6.00
Implied upside324.31%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy1 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders22.14%
Held by institutions14.55%
Institutions holding22
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2.05
+6.45% from price
SMA 20
1.91
+14.35% from price
SMA 50
1.73
+26.25% from price
SMA 100
1.85
+18.15% from price
SMA 200
2.40
-9.22% from price
EMA 12
2.04
+7.07% from price
EMA 26
1.90
+14.91% from price
EMA 50
1.83
+19.04% from price
RSI (14)
68.6
Neutral
MACD (12,26,9)
0.14
Hist 0.04
ATR (14)
0.18
8.06% of price
Realised vol 30D
54.5%
Annualised
Bollinger upper
2.27
20, 2σ
Bollinger lower
1.54
20, 2σ
50 / 200 cross
Death
1.73 vs 2.40
Trend bias
Below 200
-9.22%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.61
More volatile than market
Correlation to SPY
0.29
Largely independent
Realised vol 30D
54.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-69.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.18
8.06% of price
Beta (reported)
0.59
5Y monthly, from filing
Short interest
Shares short
96.85K
Prior 133.81K
Change vs prior
-27.6%
Shorts covering
% of float
1.55%
Normal
% of shares out
1.45%
Against total outstanding
Days to cover
3.4
Liquid
Float
5.48M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| May 20, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 13, 26 | HC Wainwright & Co. | INITIATED | — | Buy |
| Apr 8, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Dec 8, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Sep 22, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| May 30, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Apr 21, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Feb 5, 24 | Maxim Group | DOWNGRADE | Buy | Hold |
| Apr 3, 23 | Maxim Group | MAINTAINED | — | Buy |
| Feb 15, 23 | Maxim Group | MAINTAINED | — | Buy |
| Jan 20, 23 | Maxim Group | MAINTAINED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateJul 29, 2019
Last split1:200
Split dateMay 28, 2024
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-01
Corporate Changes & Voting Matters
8-K · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-07-23
Corporate Changes & Voting Matters
8-K · 2026-07-02
Offering Registrations
S-3 · 2026-06-25
Corporate Changes & Voting Matters
8-K · 2026-06-03
Corporate Changes & Voting Matters
8-K · 2026-05-27
Headlines
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
GlobeNewswire · 6d ago
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
GlobeNewswire · 23d ago
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · 29d ago
SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade
Zacks · 49d ago
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
GlobeNewswire · 55d ago
Sintx Technologies, Inc. Q2 2026 Earnings Call Summary
Moby · 56d ago
SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ...
GuruFocus.com · 56d ago
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
GlobeNewswire · 57d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.